Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Artivion (AORT)

Artivion names CFO Lance Berry chief operating officer; CMO Marshall Stanton retires

Neutral Impact 3 of 5 leadership Written later

Artivion's board appointed Chief Financial Officer Lance A. Berry as Chief Operating Officer, effective August 11, 2025, while he keeps his CFO and Treasurer roles. Chief Medical Officer Marshall S. Stanton will retire effective March 31, 2026, and the company expects him to provide advisory and transition services for up to one year afterward. The filing discloses no financial results, and the changes are leadership and compensation matters.

Key points

  • Lance A. Berry appointed COO by the board on August 6, 2025, effective August 11, 2025, in addition to his CFO and Treasurer roles
  • Berry's compensation includes a $540,000 base salary, a bonus target of 70% of base salary, and a target equity grant of $2,250,000 starting in 2026
  • Marshall S. Stanton, Senior Vice President, Clinical Research and Chief Medical Officer, will retire effective March 31, 2026, with no disagreement cited
  • Stanton is expected to provide strategic advice and transition services for up to one year after his retirement date

The filing

CompanyArtivion (AORT)
Form8-K, current report
Filed with the SECAug 11, 2025, 1:18 PM ET
Accession number0000784199-25-000136

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:59 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 11, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.